Reuters logo
BRIEF-Sonoma Pharmaceuticals posts Q2 loss $‍0.67/shr from continuing operations​
2017年11月9日 / 晚上10点08分 / 9 天前

BRIEF-Sonoma Pharmaceuticals posts Q2 loss $‍0.67/shr from continuing operations​

Nov 9 (Reuters) - Sonoma Pharmaceuticals Inc

* Sonoma Pharmaceuticals reports robust top line growth for second quarter FY 2018 with 61 pct product revenue growth and total revenue of $4.3 million

* Q2 revenue $4.3 million versus $2.8 million

* Sonoma Pharmaceuticals qtrly loss per share from continuing operations​ $‍0.67 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below